Recent advances towards the clinical application of DNA vaccines

A D Bins1, J H van den Berg, K Oosterhuis

  • 1Division of Medical Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

Insights

DNA vaccination offers therapeutic potential against pathogens and cancer. Research is exploring ways to enhance DNA vaccine delivery and immune response for improved clinical outcomes.

Area of Science:

  • Immunology
  • Vaccinology
  • Molecular Biology

Background:

  • DNA vaccination is a promising therapeutic strategy for intracellular pathogens and cancer.
  • It involves using DNA to stimulate an immune response against target antigens.

Purpose of the Study:

  • To provide an introduction to DNA vaccination.
  • To review pre-clinical and clinical successes.
  • To discuss methods for improving DNA vaccine delivery and immunogenicity.

Main Methods:

  • Literature review of pre-clinical and clinical studies on DNA vaccination.
  • Analysis of DNA vaccine attributes, mechanism of action, and safety.
  • Exploration of strategies to enhance vaccine delivery and immunogenicity.

Main Results:

  • DNA vaccination has shown pre-clinical success and some clinical achievements.
  • Current clinical results indicate a need for improvement in efficacy.
  • Various methods are being investigated to boost DNA vaccine performance.

Conclusions:

  • DNA vaccination holds significant therapeutic promise.
  • Enhancements in delivery and immunogenicity are crucial for clinical success.
  • Future developments will determine the clinical relevance of DNA vaccination.

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
The Central Dogma01:20

The Central Dogma

The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
Recombinant DNA01:09

Recombinant DNA

Overview
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...